Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
TaiMed Announces Significant Progress in Clinical Trials for New HIV Treatment 2023-10-16 21:00
I-Mab Announces Phase 1 Data of Givastomig at ESMO 2023 2023-10-16 20:00
SeekIn Presents New Validation Studies of OncoSeek Multi-cancer Early Detection test at Early Detection of Cancer Conference in London 2023-10-16 20:00
CANbridge Announces Full Enrollment Reached in the Core Part of The CAN103 Phase 2 Trial for Gaucher Disease in China 2023-10-16 13:38
Ascentage Pharma and AstraZeneca Enter into Clinical Collaboration on the Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Combination with BTK Inhibitor Acalabrutinib in Treatment-Naïve Patients with First-Line CLL/SLL 2023-10-16 09:23
Nona Biosciences and INGENIA Therapeutics Enter into Collaboration Agreement 2023-10-13 23:26
Actinogen to present progress on Phase 2 trials at the BIO Investor Forum, San Francisco and Clinical Trials on Alzheimer's Disease (CTAD) Conference, Boston 2023-10-13 20:00
Inmagene Doses First Patient in Phase 2a Trial of IMG-007, an Anti-OX40 Monoclonal Antibody with an Extended Half-life, for the Treatment of Alopecia Areata 2023-10-13 20:00
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023-10-13 09:00
Global Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Treatment-Naïve Patients with CLL/SLL Approved by the China CDE 2023-10-13 08:22
Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ovarian cancer therapy 2023-10-13 03:00
CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma: Two Patients Achieved over 7 Years of Disease-free Survival 2023-10-12 20:50
MediLink Therapeutics Announces Strategic Collaboration and Worldwide License Agreement with BioNTech to develop next-generation anti-cancer antibody-drug conjugate 2023-10-12 19:00
Asieris Unveiled Results of Its Phase III Clinical Study for APL-1706, an Imaging Drug for Diagnosis or Surgery of Bladder Cancer, at the SIU 2023 Congress 2023-10-12 18:49
MicuRx announces poster presentation and participation in ID Week 2023 Conference 2023-10-11 23:33
Kintor Pharma Announces the Approval for Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China 2023-10-11 17:20
TaiGen Enters Exclusive License Agreement with YSP 2023-10-11 11:24
GC Biopharma Shares its Successful HR System Transformation at SAP Success Connect 2023 2023-10-11 08:49
Lunit to Showcase 9 AI-based Research Results at ESMO 2023 2023-10-10 21:00
I-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1BB Bispecific Antibody TJ-L14B/ABL503 2023-10-10 20:00
1 37 38 39 40 41 222